GLEASON MK[au] - Search Results

Year	Number of Results
1973	1
1974	2
1976	1
1979	1
2012	2
2013	2
2014	2
2015	1
2016	1
2018	1
2019	1
2024	0

1

Management of Palpable Pediatric Breast Masses With Ultrasound Characteristics of Fibroadenoma: A More Conservative Approach.

Omar L, Gleason MK, Pfeifer CM, Sharma P, Kwon JK. Omar L, et al. Among authors: gleason mk. AJR Am J Roentgenol. 2019 Feb;212(2):450-455. doi: 10.2214/AJR.17.19482. Epub 2018 Nov 26. AJR Am J Roentgenol. 2019. PMID: 30476459

2

An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes.

Ross JA, Tolar J, Spector LG, DeFor T, Lund TC, Weisdorf DJ, Langer E, Hooten AJ, Thyagarajan B, Gleason MK, Wagner JE, Robien K, Verneris MR. Ross JA, et al. Among authors: gleason mk. Biol Blood Marrow Transplant. 2015 Jan;21(1):81-8. doi: 10.1016/j.bbmt.2014.09.023. Epub 2014 Oct 6. Biol Blood Marrow Transplant. 2015. PMID: 25300867 Free PMC article.

3

Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.

Vallera DA, Zhang B, Gleason MK, Oh S, Weiner LM, Kaufman DS, McCullar V, Miller JS, Verneris MR. Vallera DA, et al. Among authors: gleason mk. Cancer Biother Radiopharm. 2013 May;28(4):274-82. doi: 10.1089/cbr.2012.1329. Epub 2013 Apr 23. Cancer Biother Radiopharm. 2013. PMID: 23611188 Free PMC article.

4

Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells.

Schmohl JU, Gleason MK, Dougherty PR, Miller JS, Vallera DA. Schmohl JU, et al. Among authors: gleason mk. Target Oncol. 2016 Jun;11(3):353-61. doi: 10.1007/s11523-015-0391-8. Target Oncol. 2016. PMID: 26566946 Free PMC article.

5

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

Gleason MK, Ross JA, Warlick ED, Lund TC, Verneris MR, Wiernik A, Spellman S, Haagenson MD, Lenvik AJ, Litzow MR, Epling-Burnette PK, Blazar BR, Weiner LM, Weisdorf DJ, Vallera DA, Miller JS. Gleason MK, et al. Blood. 2014 May 8;123(19):3016-26. doi: 10.1182/blood-2013-10-533398. Epub 2014 Mar 20. Blood. 2014. PMID: 24652987 Free PMC article.

6

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.

Gleason MK, Lenvik TR, McCullar V, Felices M, O'Brien MS, Cooley SA, Verneris MR, Cichocki F, Holman CJ, Panoskaltsis-Mortari A, Niki T, Hirashima M, Blazar BR, Miller JS. Gleason MK, et al. Blood. 2012 Mar 29;119(13):3064-72. doi: 10.1182/blood-2011-06-360321. Epub 2012 Feb 8. Blood. 2012. PMID: 22323453 Free PMC article.

7

Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.

Wiernik A, Foley B, Zhang B, Verneris MR, Warlick E, Gleason MK, Ross JA, Luo X, Weisdorf DJ, Walcheck B, Vallera DA, Miller JS. Wiernik A, et al. Among authors: gleason mk. Clin Cancer Res. 2013 Jul 15;19(14):3844-55. doi: 10.1158/1078-0432.CCR-13-0505. Epub 2013 May 20. Clin Cancer Res. 2013. PMID: 23690482 Free PMC article.

8

Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.

Gleason MK, Verneris MR, Todhunter DA, Zhang B, McCullar V, Zhou SX, Panoskaltsis-Mortari A, Weiner LM, Vallera DA, Miller JS. Gleason MK, et al. Mol Cancer Ther. 2012 Dec;11(12):2674-84. doi: 10.1158/1535-7163.MCT-12-0692. Epub 2012 Oct 17. Mol Cancer Ther. 2012. PMID: 23075808 Free PMC article.

9

Isolation and characterization of S49 lymphoma cells deficient in beta-adrenergic receptors: relation of receptor number to activation of adenylate cyclase.

Johnson GL, Bourne HR, Gleason MK, Coffino P, Insel PA, Melmon KL. Johnson GL, et al. Among authors: gleason mk. Mol Pharmacol. 1979 Jan;15(1):16-27. Mol Pharmacol. 1979. PMID: 34089 No abstract available.

10

Regulation of phosphate metabolism in Neurospora crassa. Characterization of regulatory mutants.

Lehman JF, Gleason MK, Ahlgren SK, Metzenberg RL. Lehman JF, et al. Among authors: gleason mk. Genetics. 1973 Sep;75(1):61-73. doi: 10.1093/genetics/75.1.61. Genetics. 1973. PMID: 4271653 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year